Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
6 hedge funds and large institutions have $60K invested in Guardion Health Sciences, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
233% more capital invested
Capital invested by funds: $18K → $60K (+$42K)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
50% more funds holding
Funds holding: 4 → 6 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$25.8K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$18.8K |
| 3 |
HF
HRT Financial
New York
|
+$9.51K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.34K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$226 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$14K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
GHSI Hedge Fund Activity: Q3 2019 in Review
6 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q3 2019, worth a combined $60K — up 233% from $18K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GHSI positions and 3 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $25.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $14K sold.
- 6 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q3 2019, up from 4 in Q2 2019.
- Funds reported $60K of Guardion Health Sciences, Inc. Common Stock stock for Q3 2019, up 233% quarter-over-quarter.
- 5 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q3 2019 and 3 closed out, a net change of +2 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q3 2019 was Virtu Financial, an estimated $25.8K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q3 2019 was Citadel Advisors, an estimated $14K sold.
Based on aggregated 13F filings for Q3 2019.